Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;116:588-590
doi: 10.1161/CIRCULATIONAHA.107.716662
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by von Haehling, S.
Right arrow Articles by Anker, S. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by von Haehling, S.
Right arrow Articles by Anker, S. D.
Related Collections
Right arrow Other heart failure

(Circulation. 2007;116:588-590.)
© 2007 American Heart Association, Inc.


Editorial

Tipping the Scale

Heart Failure, Body Mass Index, and Prognosis

Stephan von Haehling, MD; Tamara B. Horwich, MD; Gregg C. Fonarow, MD; Stefan D. Anker, MD, PhD

From the Division of Applied Cachexia Research, Department of Cardiology, Charité Medical School, Campus Virchow Klinikum, Berlin, Germany (S.v.H., S.D.A.), and Ahmanson–UCLA Cardiomyopathy Center, University of California at Los Angeles Medical Center, Los Angeles (T.B.H., G.C.F.).

Correspondence to Professor Stefan D. Anker, Division of Applied Cachexia Research, Department of Cardiology, Charité, Campus Virchow-Klinik, Augustenburger Platz 1, D-13353 Berlin, Germany. E-mail s.anker@cachexia.de


Key Words: Editorials • heart failure • obesity • prognosis


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

Obesity has reached endemic proportions. The World Health Organization has estimated that >1 billion adults are overweight worldwide, and 300 million of them are clinically obese.1 In the general population up to 60 to 65 years of age, a higher body mass index (BMI) is associated with an increased risk for cardiovascular events and new-onset heart failure (HF). An increasing number of patients with chronic illness are obese. Of patients with chronic HF, >50% are in the overweight or obese categories.2 Although it was presumed that obesity would further increase mortality risk in patients with established HF, a number of recent studies have indicated that BMI is actually inversely associated with long-term mortality in chronic HF, the so-called obesity paradox.3

Article p 627

In this issue of Circulation, a retrospective analysis of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) trial program by Kenchaiah et al4 on the relationship between BMI and survival and other important clinical end points is reported. The authors analyzed data from all 7599 patients with symptomatic chronic HF who received candesartan (n=3803) or placebo (n=3796) and who were either angiotensin-converting enzyme inhibitor naïve or already treated with such a drug. Patients were in New York Heart Association classes II through IV, and their left ventricular ejection fractions were distributed across a wide range, with a mean value of 39%. All subjects were followed up for a median of 37.7 months. Kenchaiah et al subgrouped the patients according to different . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
Eur J Heart FailHome page
L. Frankenstein, C. Zugck, M. Nelles, D. Schellberg, H. A. Katus, and B. A. Remppis
The obesity paradox in stable chronic heart failure does not persist after matching for indicators of disease severity and confounders
Eur J Heart Fail, December 1, 2009; 11(12): 1189 - 1194.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
T. E. Strandberg, A. Y. Strandberg, V. V. Salomaa, K. H. Pitkala, R. S. Tilvis, J. Sirola, and T. A. Miettinen
Explaining the obesity paradox: cardiovascular risk, weight change, and mortality during long-term follow-up in men
Eur. Heart J., July 2, 2009; 30(14): 1720 - 1727.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Kalantar-Zadeh, D. L. Regidor, C. P. Kovesdy, D. Van Wyck, S. Bunnapradist, T. B. Horwich, and G. C. Fonarow
Fluid Retention Is Associated With Cardiovascular Mortality in Patients Undergoing Long-Term Hemodialysis
Circulation, February 10, 2009; 119(5): 671 - 679.
[Abstract] [Full Text] [PDF]